Vyacheslav L. Lvov - Search Results

Year	Number of Results
2009	2
2010	1
2012	1
2014	1
2016	1
2019	1
2022	1
2023	1
2024	0

1

A Pentavalent Shigella flexneri LPS-Based Vaccine Candidate Is Safe and Immunogenic in Animal Models.

Ledov VA, Golovina ME, Alkhazova BI, Lvov VL, Kovalchuk AL, Aparin PG. Ledov VA, et al. Among authors: lvov vl. Vaccines (Basel). 2023 Feb 3;11(2):345. doi: 10.3390/vaccines11020345. Vaccines (Basel). 2023. PMID: 36851223 Free PMC article.

2

Molecular Lipopolysaccharide Di-Vaccine Protects from Shiga-Toxin Producing Epidemic Strains of Escherichia coli O157:H7 and O104:H4.

Dyatlov IA, Svetoch EA, Mironenko AA, Eruslanov BV, Firstova VV, Fursova NK, Kovalchuk AL, Lvov VL, Aparin PG. Dyatlov IA, et al. Among authors: lvov vl. Vaccines (Basel). 2022 Nov 1;10(11):1854. doi: 10.3390/vaccines10111854. Vaccines (Basel). 2022. PMID: 36366362 Free PMC article.

3

Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.

Ledov VA, Golovina ME, Markina AA, Knirel YA, L'vov VL, Kovalchuk AL, Aparin PG. Ledov VA, et al. Vaccine. 2019 Feb 14;37(8):1062-1072. doi: 10.1016/j.vaccine.2018.12.067. Epub 2019 Jan 19. Vaccine. 2019. PMID: 30670300 Free PMC article.

4

Muropeptides trigger distinct activation profiles in macrophages and dendritic cells.

Pashenkov MV, Popilyuk SF, Alkhazova BI, L'vov VL, Murugin VV, Fedenko ES, Khaitov RM, Pinegin BV. Pashenkov MV, et al. Int Immunopharmacol. 2010 Aug;10(8):875-82. doi: 10.1016/j.intimp.2010.04.025. Epub 2010 May 10. Int Immunopharmacol. 2010. PMID: 20438865

5

A similarity in the O-acetylation pattern of the O-antigens of Shigellaflexneri types 1a, 1b, and 2a.

Perepelov AV, L'vov VL, Liu B, Senchenkova SN, Shekht ME, Shashkov AS, Feng L, Aparin PG, Wang L, Knirel YA. Perepelov AV, et al. Carbohydr Res. 2009 Mar 31;344(5):687-92. doi: 10.1016/j.carres.2009.01.004. Epub 2009 Jan 14. Carbohydr Res. 2009. PMID: 19246033

6

The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue.

Dagil YA, Arbatsky NP, Alkhazova BI, L'vov VL, Mazurov DV, Pashenkov MV. Dagil YA, et al. PLoS One. 2016 Aug 11;11(8):e0160784. doi: 10.1371/journal.pone.0160784. eCollection 2016. PLoS One. 2016. PMID: 27513337 Free PMC article.

7

Shigella flexneri O-antigens revisited: final elucidation of the O-acetylation profiles and a survey of the O-antigen structure diversity.

Perepelov AV, Shekht ME, Liu B, Shevelev SD, Ledov VA, Senchenkova SN, L'vov VL, Shashkov AS, Feng L, Aparin PG, Wang L, Knirel YA. Perepelov AV, et al. FEMS Immunol Med Microbiol. 2012 Nov;66(2):201-10. doi: 10.1111/j.1574-695X.2012.01000.x. Epub 2012 Jul 17. FEMS Immunol Med Microbiol. 2012. PMID: 22724405 Free article.

8

A new ethanolamine phosphate-containing variant of the O-antigen of Shigella flexneri type 4a.

Perepelov AV, L'vov VL, Liu B, Senchenkova SN, Shekht ME, Shashkov AS, Feng L, Aparin PG, Wang L, Knirel YA. Perepelov AV, et al. Carbohydr Res. 2009 Aug 17;344(12):1588-91. doi: 10.1016/j.carres.2009.03.022. Epub 2009 Mar 25. Carbohydr Res. 2009. PMID: 19376498

9

Structure elucidation and gene cluster annotation of the O-antigen of Escherichia coli O39; application of anhydrous trifluoroacetic acid for selective cleavage of glycosidic linkages.

Perepelov AV, Filatov AV, Wang Q, L'vov VL, Qian Y, Shashkov AS, Wang L, Knirel YA. Perepelov AV, et al. Carbohydr Res. 2014 Mar 31;388:30-6. doi: 10.1016/j.carres.2014.02.013. Epub 2014 Feb 18. Carbohydr Res. 2014. PMID: 24607538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year